Skip to main content
SpringerLink
Log in

Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence

A Source of Evidence and Analysis for Decision Making Internationally

  • Editorial
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. House of Commons Health Committee. National Institute for Health and Clinical Excellence. Volume I: report, together with formal minutes. London: The Stationery Office Limited, 2007

    Google Scholar 

  2. Barham L. Single technology appraisals by NICE: are they delivering faster guidance to the NHS? Pharmacoeconomics 2008; 26 (12): 1037–43

    Article  PubMed  Google Scholar 

  3. Kaltenthaler E, Tappenden P, Booth A, et al. Comparing methods for full versus single technology appraisal: a case study of docetaxel and paclitaxel for early breast cancer. Health Policy 2008; 87: 389–400

    Article  PubMed  Google Scholar 

  4. Rodgers M, Griffin S, Paulden M, et al. Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal. Pharmacoeconomics 2010: 28 (5): 351–62

    Article  PubMed  Google Scholar 

  5. Towse A, Garrison Jr LP. Cant get no satisfaction? Will pay for performance help? Toward an economic framework for understanding performance-based risk-sharing agreements for innovative medical products. Pharmacoeconomics 2010; 28 (2): 93–102

    Article  PubMed  Google Scholar 

  6. MacLeod S, Mitton C. We know accurately only when we know little. Pharmacoeconomics 2010; 28 (2): 105–7

    Article  PubMed  Google Scholar 

  7. Menon D, McCabe CJ, Stafinski T, et al. Principles of design of access with evidence development approaches: a consensus statement from the Banff Summitt. Pharmacoeconomics 2010; 28 (2): 109–11

    Article  PubMed  Google Scholar 

  8. Stafinski T, McCabe CJ, Menon D. Funding the unfundable: mechanisms for managing uncertainty in decisions on the introduction of new and innovative technologies into healthcare systems. Pharmacoeconomics 2010; 28 (2): 113–42

    Article  PubMed  Google Scholar 

  9. McCabe CJ, Stafinski T, Edlin R, et al. Access with evidence development schemes: a framework for description and evaluation. Pharmacoeconomics 2010; 28 (2): 143–52

    Article  PubMed  Google Scholar 

  10. Mohr PE, Tunis SR. Access with evidence development: the US experience. Pharmacoeconomics 2010; 28 (2): 153–62

    Article  PubMed  Google Scholar 

  11. Briggs A, Ritchie K, Fenwick E, et al. Access with evidence development in the UK: past experience, current initiatives and future potential. Pharmacoeconomics 2010; 28 (2): 163–70

    Article  PubMed  Google Scholar 

  12. Bagust A, Greenhalgh J, Boland A, et al. Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal. Pharmacoeconomics. In press

  13. National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008

    Google Scholar 

  14. Barbieri M, Hawkins N, Sculpher MJ. Who does the numbers? The role of third-party technology assessments to inform health systems’ decision-making about the funding of health technologies. Value Health 2009; 12: 193–201

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Mark Sculpher is part of an Evidence Review Group based at the University of York, which receives funding from the UK National Institute for Health Research Health Technology Assessment Programme.

Author information

Authors and Affiliations

  1. Centre for Health Economics, University of York, Heslington, York, YO10 5DD, UK

    Mark Sculpher (Professor of Health Economics)

Authors
  1. Mark Sculpher
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mark Sculpher.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sculpher, M. Single Technology Appraisal at the UK National Institute for Health and Clinical Excellence. Pharmacoeconomics 28, 347–349 (2010). https://doi.org/10.2165/11535680-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11535680-000000000-00000

Search

Navigation